Almaty, Kazakhstan
The $102 million Central Reference Laboratory (CRL) is being constructed in Kazakhstan to support research on emerging infectious diseases and pathogens. The 87,000-sf biocontainment facility will provide 5,400 sf of BSL-3 space as well as BSL-2 research areas. The project is being created in collaboration with the U.S. Defense Threat Reduction Agency and will be affiliated with the Kazakhstan Scientific Center for Quarantine and Zoonotic Diseases. The CRL is located in Almaty and is expected to open in 2015.
Source
